Celldex Therapeutics Inc (CLDX)

10.69 +0.33  +3.19% NASDAQ Jul 15, 16:58 Delayed 2m USD

Celldex Therapeutics Cash from Operations (TTM):

-45.29M for March 31, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Operations (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Operations (TTM) Data

View and export this data going back to 1985. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 -45.29M
Dec. 31, 2019 -46.42M
Sept. 30, 2019 -50.84M
June 30, 2019 -54.09M
March 31, 2019 -60.45M
Dec. 31, 2018 -75.24M
Sept. 30, 2018 -79.33M
June 30, 2018 -89.30M
March 31, 2018 -92.69M
Dec. 31, 2017 -99.93M
Sept. 30, 2017 -100.76M
June 30, 2017 -100.35M
March 31, 2017 -113.40M
Dec. 31, 2016 -113.04M
Sept. 30, 2016 -106.43M
June 30, 2016 -110.27M
March 31, 2016 -101.20M
Dec. 31, 2015 -98.89M
Sept. 30, 2015 -107.36M
June 30, 2015 -106.16M
March 31, 2015 -102.25M
Dec. 31, 2014 -101.54M
Sept. 30, 2014 -94.28M
June 30, 2014 -85.14M
March 31, 2014 -82.34M
   
Dec. 31, 2013 -67.67M
Sept. 30, 2013 -66.04M
June 30, 2013 -59.53M
March 31, 2013 -53.43M
Dec. 31, 2012 -49.78M
Sept. 30, 2012 -45.83M
June 30, 2012 -42.94M
March 31, 2012 -40.35M
Dec. 31, 2011 -35.66M
Sept. 30, 2011 -32.30M
June 30, 2011 -31.99M
March 31, 2011 -32.30M
Dec. 31, 2010 -30.37M
Sept. 30, 2010 -35.20M
June 30, 2010 -32.96M
March 31, 2010 -31.26M
Dec. 31, 2009 -29.87M
Sept. 30, 2009 -17.73M
June 30, 2009 -21.21M
March 31, 2009 17.04M
Dec. 31, 2008 18.28M
Sept. 30, 2008 13.63M
June 30, 2008 27.56M
March 31, 2008 -10.96M
Dec. 31, 2007 -9.125M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Benchmarks

Benchmarks
Curis Inc -27.99M
T2 Biosystems Inc -47.23M
ARCA biopharma Inc -4.921M

Cash from Operations (TTM) Range, Past 5 Years

Minimum -113.40M Mar 2017
Maximum -45.29M Mar 2020
Average -86.59M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.